Enanta Pharmaceuticals Email Formats
Biotechnology Research • 
Watertown, Massachusetts, United States • 101-200 Employees
Enanta Pharmaceuticals Email Formats
Enanta Pharmaceuticals uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@enanta.com), used 52.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@enanta.com | 52.6% |
{first initial}{last name} | jdoe@enanta.com | 45.3% |
{last name}{last name} | doedoe@enanta.com | 1.1% |
{last name} | doe@enanta.com | 1.1% |
Key Contacts at Enanta Pharmaceuticals
Ed Oconnell
Senior Director, Business Development
Luke Hubbard
Senior Director, Strategic Talent
Mike Rokas
Executive Director & Head, Program Management
Robert Mocmc
Senior Director, Cmc Drug Product Development
Manami Shizuka
Executive Director, Research Project Management
Lindsey Theriault
Associate Director, Accounting & Assistant Controller
Christopher Harris
Medical Director
Jeffrey Higgins
Executive Director Of Facilities And Lab Operations At Enanta Pharmaceuticals
Kristin Baptista
Director Of Fp&A
Timothy Abrahamsen
Director, Clinical Operations
Company overview
| Headquarters | 500 Arsenal Street, Watertown, MA 02472, US |
| Phone number | +16176070800 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Virology And Immunology |
| Founded | 1995 |
| Employees | 101-200 |
| Socials |
About Enanta Pharmaceuticals
Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic and acute hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET® (U.S.) and MAVIRET® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta’s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta’s operations. Please visit www.enanta.com for more information.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Enanta Pharmaceuticals has 57 employees across 11 departments.
Departments
Number of employees
Funding Data
Explore Enanta Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
Enanta Pharmaceuticals Tech Stack
Discover the technologies and tools that power Enanta Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Form builders
JavaScript frameworks
JavaScript libraries
Miscellaneous
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Webmail
Miscellaneous
Switzerland
Finland
Saudi Arabia
Germany
United Kingdom
Frequently asked questions
4.8
40,000 users
